Imaging findings at the time of relapse and overall patient’s treatment course. (A) Magnetic resonance imaging of the skull at the time of relapse. Arrows indicate areas of disease. (B) Clinical treatment course (top axis) and disease burden as represented by FIP1L1-RARA fusion identified by FISH cells (left y-axis) and quantitative PCR (right y-axis).